" /> Obinutuzumab Followed by Gemcitabine/Glofitamab/Oxaliplatin Regimen - CISMeF





Preferred Label : Obinutuzumab Followed by Gemcitabine/Glofitamab/Oxaliplatin Regimen;

NCIt synonyms : Obinutuzumab Followed by GemOx/Glofitamab Regimen; GemOx/Obinutuzumab/Glofitamab; GemOx-Glofitamab-Obinutuzumab; GemOx/Glofitamab/Obinutuzumab Regimen; Obinutuzumab Followed by GemOx/Glofitamab-gxbm Regimen; Gemcitabine/Glofitamab/Obinutuzumab/Oxaliplatin Regimen; Gazyva Followed by Gemcitabine/Oxaliplatin Plus Columvi; Gazyva Followed by GemOx-Columvi; Gazyva Followed by GemOx Plus Columvi; GemOx/Glofitamab-gxbm/Obinutuzumab;

NCIt definition : A regimen consisting of obinutuzumab followed by gemcitabine, glofitamab and oxaliplatin that can be used for the treatment of diffuse large B-cell lymphoma (DLBCL).;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.